Clinical trials recruiting in Jiangxi, China
9
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 1Phase 2 2Phase 3 3Phase 4 1Not applicable 3
Conditions recruiting in Jiangxi, China
Recruiting trials in Jiangxi, China
- A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Chinese Psoriasis Real World Evidence Research
- Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN)
- Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
- Prophylactic Irradiation to the Contralateral Breast for BCAs Patients
- Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
- Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
- The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
Common questions
How many clinical trials are recruiting in Jiangxi, China?
9 recruiting trials have at least one study site in Jiangxi, China.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.